Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial
Chris Harding,
Helen Mossop,
Tara Homer,
Thomas Chadwick,
William King,
Sonya Carnell,
Jan Lecouturier,
Alaa Abouhajar,
Luke Vale,
Gillian Watson,
Rebecca Forbes,
Stephanie Currer,
Robert Pickard,
Ian Eardley,
Ian Pearce,
Nikesh Thiruchelvam,
Karen Guerrero,
Katherine Walton,
Zahid Hussain,
Henry Lazarowicz,
Ased Ali March 2022
Related
- Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial
- Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT
- ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): Study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial
- Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)
- The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol